AC Immune (ACIU) Other Non-Current Assets (2014 - 2026)

AC Immune's (ACIU) quarterly Other Non-Current Assets came in at $747.0 million in Q1 2026, up 114712.68% year-on-year from N/an in Q1 2025, and up 2.24% on a QoQ basis from $730.7 million in Q4 2025.

AC Immune (ACIU) Other Non-Current Assets (2014 - 2026) Analysis & Trends

AC Immune (ACIU) has 13 years of Other Non-Current Assets data on file, last reported at $747.0 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 114712.68% year-over-year to $747.0 million in Q1 2026; TTM through Mar 2026 was $747.0 million, a 114712.68% increase from a year earlier, with the FY2025 full-year figure at $704.4 million, up 148587.38% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $747.0 million, up from $730.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ACIU reached as high as $747.0 million in Q1 2026 and fell as low as $373799.8 in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $156.4 million across 5 years, with a median of $478996.0 in 2024.
  • Across the five-year window, Other Non-Current Assets tumbled 99.91% in 2022 and soared 154139.91% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $374725.9 in 2022, then jumped by 108506.04% to $407.0 million in 2023, then plunged by 99.88% to $473731.6 in 2024, then surged by 154139.91% to $730.7 million in 2025, then rose by 2.24% to $747.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $747.0 million in Q1 2026, $730.7 million in Q4 2025, and $730064.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 AC Immune 225.68 Mn 225.68 Mn - 747.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 747.05 Mn
Dec 31, 2025 730.68 Mn
Sep 30, 2025 730,063.96
Jun 30, 2025 705,407.89
Mar 31, 2025 650,666.56
Dec 31, 2024 473,731.57
Sep 30, 2024 478,996.01
Jun 30, 2024 458,904.30
Mar 31, 2024 475,458.16
Dec 31, 2023 406.97 Mn
Sep 30, 2023 408,707.08
Jun 30, 2023 401,495.37
Mar 31, 2023 390,299.69
Dec 31, 2022 374,725.91
Sep 30, 2022 373,799.85
Jun 30, 2022 374.82 Mn
Mar 31, 2022 393.06 Mn
Dec 31, 2021 393.67 Mn
Sep 30, 2021 395.35 Mn
Jun 30, 2021 398.08 Mn